A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy, safety and tolerability of sildenafil administered orally, as
required, approximately 1 hour prior to sexual activity to men with erectile dysfunction (ED)
associated with spinal cord injury (SCI), as well as its effects on the quality of life (QoL)
of these patients.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.